Familial defective apolipoprotein B-100: detection in the United Kingdom and Scandinavia, and clinical characteristics of ten cases
Authors:
- John GallagherJGJohn Gallagher
- John VincentJVJohn Vincent
- Richard HoulstonRHRichard Houlston
- Philippa TalmudPTPhilippa Talmud
- Alison M. DunningADAlison M. Dunning
- Mary SeedMSMary Seed
- Anders HamstenAHAnders Hamsten
- Steve E. HumphriesSHSteve E. Humphries
- Nicholas B. MyantNMNicholas B. Myant
- 1 January 1990
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 80 (3) , 235-242
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Familial defective apolipoprotein B-100: enhanced binding of monoclonal antibody MB47 to abnormal low density lipoproteins.Proceedings of the National Academy of Sciences, 1988
- High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.Heart, 1988
- SIMPLE NON-INVASIVE METHOD TO OBTAIN DNA FOR GENE ANALYSISThe Lancet, 1988
- DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial diseaseAtherosclerosis, 1988
- Familial defective apolipoprotein B-100: low density lipoproteins with abnormal receptor binding.Proceedings of the National Academy of Sciences, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Analysis of enzymatically amplified β-globin and HLA-DQα DNA with allele-specific oligonucleotide probesNature, 1986
- In vivo evidence for reduced binding of low density lipoproteins to receptors as a cause of primary moderate hypercholesterolemia.Journal of Clinical Investigation, 1986
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATIONThe Lancet, 1974